Tear fluid levels of MMP-8 are elevated in ocular rosacea--treatment effect of oral doxycycline.
about
Formulation and release behavior of doxycycline-alginate hydrogel microparticles embedded into pluronic F127 thermogels as a potential new vehicle for doxycycline intradermal sustained deliveryContact lens sensors in ocular diagnostics.The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline.Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with stevens-johnson syndrome and ocular cicatricial pemphigoid.Non-antibiotic properties of tetracyclines and their clinical application in dermatology.Rosacea - the ophthalmic perspective.The role and treatment of inflammation in dry eye disease.Analysis of the Pathogenic Factors and Management of Dry Eye in Ocular Surface DisordersDetermination of tear and serum inflammatory cytokines in patients with rosacea using multiplex bead technology.Ocular Rosacea Causing Corneal Melt in an African American Patient and a Hispanic Patient.Heparanase Overexpresses in Keratoconic Cornea and Tears Depending on the Pathologic Grade.
P2860
Q28748159-88876044-3A95-4E90-A38D-FA6391EB3252Q34448084-9D2A24E5-F873-4A72-8A1A-22BB46527BF7Q34769319-7D8F3E3B-7622-4909-A129-6020FB42D50AQ35691929-F323058F-F60D-4D39-ADDB-E4EBC9759CD6Q36991412-0F78033F-FD09-4E8D-B2F4-CCBC93E30D26Q37577236-712C9293-555B-4CB3-9AD3-007A3FE63301Q38117653-B262360D-2AAB-44B6-82A4-18EFC0A6B243Q38227612-12237130-DF9C-4594-AC45-1943A6DC9512Q38270449-C0598365-D73E-4F74-8BCC-C7829E1A626AQ41574217-0303703B-33F5-4BB4-90AD-6F697B338A74Q43814712-EB1814FA-D3E9-4CA9-BB4B-C5B171467A1AQ47124875-56B44342-6389-4535-8E52-633F28469186Q48146565-40116843-883D-4ACC-BB25-CB2581AD08E1
P2860
Tear fluid levels of MMP-8 are elevated in ocular rosacea--treatment effect of oral doxycycline.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Tear fluid levels of MMP-8 are ...... nt effect of oral doxycycline.
@ast
Tear fluid levels of MMP-8 are ...... nt effect of oral doxycycline.
@en
Tear fluid levels of MMP-8 are ...... nt effect of oral doxycycline.
@nl
type
label
Tear fluid levels of MMP-8 are ...... nt effect of oral doxycycline.
@ast
Tear fluid levels of MMP-8 are ...... nt effect of oral doxycycline.
@en
Tear fluid levels of MMP-8 are ...... nt effect of oral doxycycline.
@nl
prefLabel
Tear fluid levels of MMP-8 are ...... nt effect of oral doxycycline.
@ast
Tear fluid levels of MMP-8 are ...... nt effect of oral doxycycline.
@en
Tear fluid levels of MMP-8 are ...... nt effect of oral doxycycline.
@nl
P2093
P2860
P1476
Tear fluid levels of MMP-8 are ...... nt effect of oral doxycycline.
@en
P2093
Marjatta Kari
Marko Määttä
Matti Saari
Sirje Peltonen
Taina Tervahartiala
Timo Sorsa
P2860
P2888
P304
P356
10.1007/S00417-005-0212-3
P577
2006-01-13T00:00:00Z
P6179
1003874817